EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cytoplasmic retention of IRF3 binding Vimentin competitively with ERK1/2 mitigates acute myeloid leukemia through TFEB nuclear translocation

Manman Geng, Aili He, Qiaoyan Jin, Dongxia Liang, Xiaoyu Ren, Xiaomeng Li, Yanglong Guan, Chongyu Zhang, Yaqi Lu, Jing Zhang, Wentao Zhang, Yuanyuan Cheng und 6 weitere

Cell Communication and Signaling · 28.04.2026 · 24 (1)

DOI: 10.1186/s12964-026-02899-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Communication and Signaling, online erschienen am 28.04.2026. Verfasst von Manman Geng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Cell Nucleus, Cytoplasm, Interferon Regulatory Factor-3. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteCell NucleusCytoplasmInterferon Regulatory Factor-3VimentinBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsHumansAnimalsMiceCell DifferentiationPhosphorylationProtein BindingMice, NudeProtein TransportMAP Kinase Signaling SystemActive Transport, Cell NucleusMale

Stichwörter der Autor:innen

Acute myeloid leukemiaCell differentiationERKInterferon regulatory factor 3Vimentin

Substanzen

Interferon Regulatory Factor-3VimentinBasic Helix-Loop-Helix Leucine Zipper Transcription Factors

Autor:innen und Institutionen

  • Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China.
  • Precision Medicine Institute, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China.
  • Institute of Molecular and Translational Medicine, and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China.
  • Department of Pediatrics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China.
  • Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China.
  • Department of Joint Surgery, Xi'an Hong Hui Hospital, Xi'an Jiaotong University Health Science Center, Xi'an, 710054, Shaanxi, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Geng, M., He, A., Jin, Q., Liang, D., Ren, X., Li, X., Guan, Y., Zhang, C., Lu, Y., Zhang, J., Zhang, W., Cheng, Y., Li, Y., Ouyang, Y., Chang, K., Meng, L., Zhu, W., & Lu, S. (2026). Cytoplasmic retention of IRF3 binding Vimentin competitively with ERK1/2 mitigates acute myeloid leukemia through TFEB nuclear translocation. Cell Communication and Signaling, 24(1). https://doi.org/10.1186/s12964-026-02899-9

Vancouver

Geng M, He A, Jin Q, Liang D, Ren X, Li X, et al. Cytoplasmic retention of IRF3 binding Vimentin competitively with ERK1/2 mitigates acute myeloid leukemia through TFEB nuclear translocation. Cell Communication and Signaling. 2026;24(1). doi:10.1186/s12964-026-02899-9

BibTeX
@article{Geng2026,
  author = {Geng, Manman and He, Aili and Jin, Qiaoyan and Liang, Dongxia and Ren, Xiaoyu and Li, Xiaomeng and Guan, Yanglong and Zhang, Chongyu and Lu, Yaqi and Zhang, Jing and Zhang, Wentao and Cheng, Yuanyuan and Li, Yingnan and Ouyang, Yuanshuo and Chang, Kewei and Meng, Liesu and Zhu, Wenhua and Lu, Shemin},
  title = {Cytoplasmic retention of IRF3 binding Vimentin competitively with ERK1/2 mitigates acute myeloid leukemia through TFEB nuclear translocation},
  journal = {Cell Communication and Signaling},
  year = {2026},
  volume = {24},
  number = {1},
  doi = {10.1186/s12964-026-02899-9}
}
Kostenlos starten →